Pentose phosphate pathway
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
The pentose phosphate pathway (also called Phosphogluconate Pathway, or Hexose Monophosphate Shunt [HMP shunt]) is a cytosolic process that serves to generate NADPH and the synthesis of pentose (5-carbon) sugars. There are two distinct phases in the pathway. The first is the oxidative phase, in which NADPH is generated, and the second is the non-oxidative synthesis of 5 carbon sugars. This pathway is an alternative to glycolysis. While it does involve oxidation of glucose, its primary role is anabolic rather than catabolic.
Uses
The pathway is one of the three main ways the body creates molecules with reducing power, accounting for approximately 60% of NADPH production in humans.
One of the uses of NADPH in the cell is to prevent oxidative stress. It reduces the coenzyme glutathione which converts reactive H2O2 into H2O. If absent, the H2O2 would be converted to hydroxyl free radicals which can attack the cell.
It is also used to generate hydrogen peroxide for phagocytes.[1]
Phases
Oxidative phase
In this phase, two molecules of NADP+ are reduced to NADPH, utilizing the energy from the conversion of glucose-6-phosphate into ribulose 5-phosphate.
The entire set of reactions can be summarized as follows:
| Reactants | Products | Enzyme | Description |
| Glucose 6-phosphate + NADP+ | → 6-phosphoglucono-δ-lactone + NADPH | glucose 6-phosphate dehydrogenase | Dehydrogenation. The hemiacetal hydroxyl group located on carbon 1 of glucose 6-phosphate is converted into a carbonyl group, generating a lactone, and in the process NADPH is generated. |
| 6-phosphoglucono-δ-lactone + H2O | → 6-phosphogluconate + H+ | 6-phosphoglucolactonase | Hydrolysis |
| 6-phosphogluconate + NADP+ | → ribulose 5-phosphate + NADPH + CO2 | 6-phosphogluconate dehydrogenase | Oxidative decarboxylation. NADP+ is the electron acceptor, generating another molecule of NADPH, a CO2, and ribulose 5-phosphate. |
| ribulose 5-phosphate | ribose 5-phosphate | Phosphopentose isomerase | Isomerization. (Can also be considered part of nonoxidative phase) |
The overall reaction for this process is:
- Glucose 6-phosphate + 2 NADP+ + H2O → ribulose 5-phosphate + 2 NADPH + 2 H+ + CO2
Non-oxidative phase
Regulation
Glucose-6-phosphate dehydrogenase is the rate controlling enzyme of this pathway. It is allosterically stimulated by NADP+. The ratio of NADPH:NADP+ is normally about 100:1 in liver cytosol. This makes the cytosol a highly reducing environment. Formation of NADP+ by an NADPH utilizing pathway thus stimulates production of more NADPH.
See also
- G6PDH deficiency - A hereditary disease which disrupts the pentose phosphate pathway.
- NADPH
- RNA
References
External links
Metabolism: carbohydrate metabolism | |
|---|---|
| Anabolism | Gluconeogenesis - Glycogenesis - Photosynthesis (Carbon fixation) |
| Carbohydrate catabolism | Glycolysis - Glycogenolysis - Fermentation (Ethanol, Lactic acid) - Cellular respiration - Xylose metabolism |
| Other | Pentose phosphate pathway |
Metabolism map | ||||||
|---|---|---|---|---|---|---|
Pentose phosphate pathway
| ||||||
Metabolism: carbohydrate metabolism - pentose phosphate pathway enzymes | |
|---|---|
| oxidative | Glucose-6-phosphate dehydrogenase - 6-phosphogluconolactonase - Phosphogluconate dehydrogenase |
| nonoxidative | Phosphopentose isomerase - Phosphopentose epimerase - Transketolase - Transaldolase |
| see also disorders | |
it:Via dei pentoso fosfati he:מסלול הפנטוז פוספט ja:ペントースリン酸経路 no:Pentosefosfatshuntensv:Pentosfosfatvägen
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .



